
Aarti Drugs Q1 FY27 slides: EBITDA surges 30% on pricing recovery
Aarti Drugs Q1 FY27 slides: EBITDA surges 30% on pricing recovery
5.5Significance
1 source5.0Source trust
Top stories · Organization

Aarti Drugs Q1 FY27 slides: EBITDA surges 30% on pricing recovery